• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性浸润性乳腺癌保乳治疗的选择

Selection of breast-preservation therapy for primary invasive breast carcinoma.

作者信息

Cady B, Stone M D

机构信息

Department of Surgery, New England Deaconess Hospital, Boston, Massachusetts.

出版信息

Surg Clin North Am. 1990 Oct;70(5):1047-59. doi: 10.1016/s0039-6109(16)45229-1.

DOI:10.1016/s0039-6109(16)45229-1
PMID:2218818
Abstract

Breast-preservation treatment for primary breast cancer should not be used for all women. Women frequently excluded from consideration for such treatment or who choose not to have it may be elderly and not concerned about cosmetic appearance or live at a distance so that 6 weeks of daily trips to radiotherapy would be inconvenient or even impossible. Also, if radiotherapeutic expertise or facilities are not available, a breast-preservation program is difficult. In Massachusetts, a full course of just over 6000 cGy (4500 cGy to the whole breast and a 1600-cGy local boost) costs roughly $6000. Thus, breast preservation is more expensive than mastectomy even with reconstruction, as patients still frequently require a hospital admission with general anesthesia for an axillary dissection. Although insurance policies cover such expenses, patients who do not have insurance or have inadequate coverage may find the extra expense of the breast-preservation technique burdensome or impossible. Women with a small breast and a proportionately large cancer may have an unsatisfactory cosmetic outcome after appropriate lumpectomy. The cosmetic result in such patients frequently cannot be predicted beforehand; this fact adds emphasis to the need for a two-step process of lumpectomy and then re-evaluation of the cosmetic outcome as well as pathologic features for decisions regarding breast preservation. Finally, women may have strikingly different attitudes toward breast preservation than expected by the surgeon. For some women, the urge to preserve the breast is so strong that they will accept virtually any risk to achieve this option, whereas for other women, the constant anxiety about a recurrence or undergoing radiation therapy is traumatic enough that they readily accept mastectomy. In our referral surgical oncology practice, roughly 60% of patients are currently treated with breast-preservation techniques; the remainder undergo mastectomy, with immediate reconstruction in approximately three fourths of the cases. The proportion of patients who elect to have breast preservation depends greatly on local medical customs and attitudes; the radiotherapeutic skills available; women's attitudes, which frequently are dependent on the local press and publicity; and the surgeon's interest and enthusiasm for such a program. There is no appropriate proportion of patients who should be treated by breast-preservation techniques, but clearly, the proportion of patients so treated increases with experience, acceptability, publicity, and availability. Thus, the selection of breast-preserving therapy for individual patients is a result of an extraordinary array of factors that need to be considered in each patient.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

原发性乳腺癌的保乳治疗并非适用于所有女性。经常被排除在这种治疗考虑范围之外或选择不接受保乳治疗的女性可能年事已高,不太在意外观,或者居住距离较远,以至于每天前往放疗六周会很不方便甚至无法做到。此外,如果缺乏放射治疗专业知识或设施,开展保乳项目也很困难。在马萨诸塞州,一个疗程略超过6000厘戈瑞(全乳照射4500厘戈瑞,局部加量1600厘戈瑞)的费用大约为6000美元。因此,即使进行乳房重建,保乳治疗也比乳房切除术更昂贵,因为患者进行腋窝淋巴结清扫时仍经常需要住院接受全身麻醉。尽管保险政策涵盖此类费用,但没有保险或保险覆盖不足的患者可能会觉得保乳技术的额外费用负担过重或无法承受。乳房较小且癌灶相对较大的女性在进行适当的肿块切除术后可能会有不尽如人意的美容效果。这类患者的美容效果往往无法预先预测;这一事实更凸显了需要采取两步走的过程,即先进行肿块切除术,然后重新评估美容效果以及病理特征,以便做出关于保乳的决策。最后,女性对保乳的态度可能与外科医生的预期大不相同。对一些女性来说,保留乳房的愿望非常强烈,以至于她们几乎会接受任何风险来实现这一选择,而对另一些女性来说,对复发或接受放射治疗的持续焦虑已经足够痛苦,以至于她们很容易接受乳房切除术。在我们的转诊外科肿瘤学实践中,目前大约60%的患者接受保乳技术治疗;其余患者接受乳房切除术,约四分之三的病例会立即进行重建。选择保乳治疗的患者比例在很大程度上取决于当地的医疗习惯和态度、现有的放射治疗技术、女性的态度(这往往取决于当地的媒体报道和宣传)以及外科医生对该项目的兴趣和热情。对于应该接受保乳技术治疗的患者,不存在合适的比例,但显然,接受这种治疗的患者比例会随着经验、可接受性、宣传和可获得性的增加而上升。因此,为个体患者选择保乳治疗是一系列特殊因素综合作用的结果,每个患者都需要考虑这些因素。(摘要截断于400字)

相似文献

1
Selection of breast-preservation therapy for primary invasive breast carcinoma.原发性浸润性乳腺癌保乳治疗的选择
Surg Clin North Am. 1990 Oct;70(5):1047-59. doi: 10.1016/s0039-6109(16)45229-1.
2
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.导管原位癌的治疗:利弊平衡尚不确定。
Prescrire Int. 2013 Dec;22(144):298-303.
3
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.非临床试验中早期乳腺癌女性不同治疗策略的心理结局
BMJ. 1990 Sep 22;301(6752):575-80. doi: 10.1136/bmj.301.6752.575.
4
Who should not undergo breast conservation?哪些人不适合进行保乳治疗?
Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021.
5
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.保留乳头的乳房切除术联合术中放疗(ELIOT):一种用于乳腺癌治疗的新型乳房切除术。
Breast Cancer Res Treat. 2006 Mar;96(1):47-51. doi: 10.1007/s10549-005-9033-7. Epub 2005 Oct 27.
6
Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?术中触摸准备细胞学检查;它在再切除乳房肿块切除术中起作用吗?
Ann Surg Oncol. 2007 Mar;14(3):1045-50. doi: 10.1245/s10434-006-9263-x. Epub 2007 Jan 6.
7
Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.既往接受过放疗的乳腺癌患者行肿块切除术及近距离放射治疗后的长期美容效果。
Am J Clin Oncol. 2009 Jun;32(3):314-8. doi: 10.1097/COC.0b013e31818af0b9.
8
Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer.保留皮肤的乳房切除术及即刻乳房重建:早期乳腺癌患者的肿瘤学风险及美学效果
Plast Reconstr Surg. 1998 Jul;102(1):49-62. doi: 10.1097/00006534-199807000-00008.
9
Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.I、II期乳腺癌的保乳治疗。芝加哥大学的经验。
Cancer. 1996 Oct 15;78(8):1722-30. doi: 10.1002/(sici)1097-0142(19961015)78:8<1722::aid-cncr12>3.0.co;2-#.
10
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.关于:罗森塔尔·迪、格拉茨坦·埃。《我们有了一种治疗方法,但疾病是什么?》,《肿瘤学家》1996年;第1期。
Oncologist. 1997;2(1):59-61.

引用本文的文献

1
Psychosocial sequelae of breast cancer and its treatment.乳腺癌及其治疗的心理社会后遗症。
Ann Behav Med. 1996 Jun;18(2):110-25. doi: 10.1007/BF02909583.
2
Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.加拿大非转移性乳腺癌的诊断和治疗方法及其相关成本。
Br J Cancer. 1999 Mar;79(9-10):1428-36. doi: 10.1038/sj.bjc.6690228.
3
Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery.早期乳腺癌的治疗:与保乳手术相关的医院特征
Am J Public Health. 1995 Oct;85(10):1432-4. doi: 10.2105/ajph.85.10.1432.